KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Assets (2016 - 2025)

Historic Return on Assets for Sarepta Therapeutics (SRPT) over the last 14 years, with Q3 2025 value amounting to 0.1%.

  • Sarepta Therapeutics' Return on Assets rose 600.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.07% for FY2024, which is 2300.0% up from last year.
  • Sarepta Therapeutics' Return on Assets amounted to 0.1% in Q3 2025, which was up 600.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Return on Assets registered a high of 0.11% during Q2 2025, and its lowest value of 0.36% during Q1 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.17% (2022), whereas its average is 0.12%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -2500bps in 2023, then soared by 3700bps in 2024.
  • Sarepta Therapeutics' Return on Assets (Quarter) stood at 0.14% in 2021, then tumbled by -55bps to 0.22% in 2022, then grew by 25bps to 0.17% in 2023, then skyrocketed by 137bps to 0.06% in 2024, then soared by 60bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.11% for Q2 2025, and 0.05% during Q1 2025.